Ajit Ramalingam - Apr 29, 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
SVP, Chief Accounting Officer
Signature
/s/ Ajit Ramalingam
Stock symbol
BIO
Transactions as of
Apr 29, 2022
Transactions value $
-$49,158
Form type
4
Date filed
5/2/2022, 02:42 PM
Previous filing
Sep 3, 2021
Next filing
Aug 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +277 +65.84% $0.00 698 Apr 29, 2022 Direct F1, F2
transaction BIO Bio-Rad A Common Stock Tax liability -$49.2K -96 -13.76% $512.06 602 Apr 29, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Options Exercise $0 -277 -25% $0.00 831 Apr 29, 2022 Bio-Rad A Common Stock 277 $0.00 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 12.1142, 5.1601, and 13.0147 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2021, 12/31/2021, and 03/31/2022, respectively.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 On April 29, 2020, the reporting person was granted 1,384 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.